Delivery Order SPE2DB20D7061-SPE2DB25FSPC7
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Phenobarbital 65 mg/mL vials. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,018.74 and is scheduled for completion by August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this requirement from its corporate office location....
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Phenobarbital 65 mg/ml vials, with a ceiling value of $4,516.61 and an ultimate completion date of September 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,494.60 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 65 mg/ml vials, with an ultimate completion date of April 8, 2025. This firm fixed price delivery order, awarded on April 7, 2025, was competitively awarded with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Phenobarbital 130 mg/mL vials valued at $3,106.84. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 5, 2025, with the place of performance located in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical vendor for federal medical procurement, specifically supporting...
- The Defense Logistics Agency awarded a $3,285.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Phenobarbital 130 mg/ml vials. The contract represents a non-set-aside competitive award with an ultimate completion date of August 29, 2025, and performance location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order valued at $2,019.16 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials. This non-set-aside, competitively awarded contract employs firm fixed pricing and was executed on April 24, 2025, with an ultimate completion date of April 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order on June 24, 2025, for Phenobarbital 65 mg/mL vials valued at $1,290.04 under a Firm Fixed Price contract type. The award, issued by the Medical Supply Chain division of the Defense Logistics Agency, requires performance at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 25, 2025. This delivery order was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Phenobarbital 65 mg/mL vials with a ceiling value of $1,133.18. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 17, 2025. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 9, 2025, for the supply of Phenobarbital 65 mg/mL vials with a ceiling value of $1,442.24. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of June 10, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division, which procures critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,562.39 to AmerisourceBergen Drug Corp for Phenobarbital 130 mg/mL vials, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor on this...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPC7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,470.98 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/ml vials. The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitive award under AmerisourceBergen's existing federal contract portfolio and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products across multiple therapeutic domains, from specialty medications to generic drugs and medical supplies supporting military readiness and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 8/5/25 |